abogen biosciences
PrivateLast Round
Series C
Extension
11/29/2021
Last Round Size
$300M
Total Funding Raised
$1.1B
Company Overview
AbogenBio is a biotechnology company specializing in the development of mRNA drugs and vaccines for infectious diseases, offering a comprehensive drug development pipeline that encompasses design, development, and production for the efficient delivery of new therapies.
Sector
Biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
abogen biosciences Comps
Related companies by embedding similarity.
abogen biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | 11/29/2021 | ||||
| Series C | 8/19/2021 | ||||
| Series B | 4/7/2021 | ||||
| Series A | 10/27/2020 |
abogen biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about abogen biosciences's valuation, stock price, and market status.
